Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Matthias Holdhoff, Nina Wagner-Johnston & Mark Roschewski. (2020) Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies. OncoTargets and Therapy 13, pages 8323-8335.
Read now
Read now
Kathryn S Nevel, Elena Pentsova & Mariza Daras. (2019) Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma. Leukemia & Lymphoma 60:7, pages 1677-1684.
Read now
Read now
Giovanni Citterio, Teresa Calimeri & Andrés J. M. Ferreri. (2018) Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma. Expert Review of Neurotherapeutics 18:5, pages 379-393.
Read now
Read now
Carrie van der Weyden & H. Miles Prince. (2016) High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from “orphan drug” to a standard-of-care?. Leukemia & Lymphoma 57:1, pages 1-3.
Read now
Read now
Danielle H. Oh, Neil Chua, Lesley Street & Douglas A. Stewart. (2016) Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplant. Leukemia & Lymphoma 57:1, pages 28-33.
Read now
Read now
Giovanni Citterio, Michele Reni & Andrés José Maria Ferreri. (2015) Present and future treatment options for primary CNS lymphoma. Expert Opinion on Pharmacotherapy 16:17, pages 2569-2579.
Read now
Read now
Articles from other publishers (37)
Ryan C. Schofield, Michael Scordo, Gunjan Shah & Dean C. Carlow. 2024. Clinical Applications of Mass Spectrometry in Drug Analysis. Clinical Applications of Mass Spectrometry in Drug Analysis
423
433
.
Lebon Delphine, Debureaux Pierre-Edouard, Royer Bruno, Gruson Bérengère, Joris Magalie, Votte Patrick, Marolleau Jean-Pierre & Morel Pierre. (2023) Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma. Medical Sciences 11:1, pages 14.
Crossref
Crossref
Sara Steffanoni, Teresa Calimeri, Sarah Marktel, Rosamaria Nitti, Marco Foppoli & Andrés J. M. Ferreri. (2023) Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review. Cancers 15:2, pages 526.
Crossref
Crossref
Kotaro Miyao, Hirofumi Yokota & R. Leo Sakemura. (2023) Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?. Frontiers in Oncology 12.
Crossref
Crossref
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, Julia Furtner, Jaime Gallego Perez-Larraya, Roger Henriksson, Andreas F Hottinger, Benjamin Kasenda, Florence Lefranc, Alexander Lossos, Catherine McBain, Matthias Preusser, Patrick Roth, Roberta Rudà, Uwe Schlegel, Riccardo Soffietti, Carole Soussain, Martin J B Taphoorn, Valérie Touitou, Michael Weller & Jacoline E C Bromberg. (2023) European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). Neuro-Oncology 25:1, pages 37-53.
Crossref
Crossref
Jing Liu, Jiayuan Guo, Xuefei Sun, Yuanbo Liu & Chunji Gao. (2022) Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Michael Scordo, Trent P. Wang, Kwang W. Ahn, Yue Chen, Sairah Ahmed, Farrukh T. Awan, Amer Beitinjaneh, Andy Chen, Victor A. Chow, Bhagirathbhai Dholaria, Narendranath Epperla, Umar Farooq, Nilanjan Ghosh, Natalie Grover, Nada Hamad, Gerhard C. Hildebrandt, Leona Holmberg, Sanghee Hong, David J. Inwards, Antonio Jimenez-Jimenez, Reem Karmali, Vaishalee P. Kenkre, Farhad Khimani, Evgeny Klyuchnikov, Maxwell M. Krem, Pashna N. Munshi, Yago Nieto, Tim Prestidge, Praveen Ramakrishnan Geethakumari, Andrew R. Rezvani, Peter A. Riedell, Sachiko Seo, Nirav N. Shah, Melhem Solh, Jean A. Yared, Mohamed A. Kharfan-Dabaja, Alex Herrera, Mehdi Hamadani & Craig S. Sauter. (2021) Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant. JAMA Oncology 7:7, pages 993.
Crossref
Crossref
Mamiko Takahashi, Ryohei Sumitani, Taiki Hori, Jumpei Murai, Shiyori Kawata, Masahiro Oura, Kimiko Sogabe, Takeshi Harada, Shiro Fujii, Hirokazu Miki, Kumiko Kagawa, Masahiro Abe & Shingen Nakamura. (2021) Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement. The Journal of Medical Investigation 68:1.2, pages 196-201.
Crossref
Crossref
Yu Yagi, Yusuke Kanemasa, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Yuki Otsuka, Yuya Kishida, Akihiko Kageyama, Takuya Shimizuguchi, Takashi Toya, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Kyoko Haraguchi, Noriko Doki, Yoshiki Okuyama, Yasushi Omuro & Tatsu Shimoyama. (2021) Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma. Medicine 100:44, pages e27733.
Crossref
Crossref
Nadav Sarid, Felix Bokstein, Deborah T. Blumenthal, Ahuva Weiss-Meilik, Lili Gibstein, Irit Avivi, Chava Perry & Ron Ram. (2020) Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients. Journal of Neuro-Oncology 151:2, pages 211-220.
Crossref
Crossref
Hua Yang, Yang Xun, Anping Yang, Fang Liu & Hua You. (2020) Advances and challenges in the treatment of primary central nervous system lymphoma. Journal of Cellular Physiology 235:12, pages 9143-9165.
Crossref
Crossref
Matthias HoldhoffMaciej M. MrugalaChristian Grommes, Thomas J. Kaley, Lode J. SwinnenCarlos Perez-HeydrichLakshmi Nayak. (2020) Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma. Journal of the National Comprehensive Cancer Network 18:11, pages 1571-1578.
Crossref
Crossref
Patricia A. Young, Daria Gaut, Davis K. Kimaiyo, Jonathan Grotts, Tahmineh Romero, John Chute, Gary Schiller, Sven de Vos, Herbert A. Eradat & John Timmerman. (2020) Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen. Clinical Lymphoma Myeloma and Leukemia 20:7, pages 468-479.
Crossref
Crossref
Caroline Houillier, Luc Taillandier, Sylvain Dureau, Thierry Lamy, Mouna Laadhari, Olivier Chinot, Cecile Moluçon-Chabrot, Pierre Soubeyran, Remy Gressin, Sylvain Choquet, Gandhi Damaj, Antoine Thyss, Julie Abraham, Vincent Delwail, Emmanuel Gyan, Laurence Sanhes, Jérôme Cornillon, Reda Garidi, Alain Delmer, Marie-Laure Tanguy, Ahmad Al Jijakli, Pierre Morel, Pascal Bourquard, Marie-Pierre Moles, Adrien Chauchet, Thomas Gastinne, Jean-Marc Constans, Adriana Langer, Antoine Martin, Patricia Moisson, Lucette Lacomblez, Nadine Martin-Duverneuil, Daniel Delgadillo, Isabelle Turbiez, Loïc Feuvret, Nathalie Cassoux, Valérie Touitou, Damien Ricard, Khê Hoang-Xuan & Carole Soussain. (2019) Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study. Journal of Clinical Oncology 37:10, pages 823-833.
Crossref
Crossref
Iyad Alnahhas, Mohammad Jawish, Mouaz Alsawas, Alicia Zukas, Larry Prokop, M. Hassan Murad & Mark Malkin. (2019) Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis. Clinical Lymphoma Myeloma and Leukemia 19:3, pages e129-e141.
Crossref
Crossref
Daria Gaut & Gary J. Schiller. (2019) Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature. International Journal of Hematology 109:3, pages 260-277.
Crossref
Crossref
Holger Dau, Philipp Kurz & Marc-Denis WeitzeKayane Mheidly, Roch Houot, Michael Scordo & Craig Moskowitz. 2019. Künstliche Photosynthese. Künstliche Photosynthese
157
166
.
Louis Royer-Perron & Khê Hoang-Xuan. (2018) Management of primary central nervous system lymphoma. La Presse Médicale 47:11-12, pages e213-e244.
Crossref
Crossref
Tommy Sheu, Sarah A. Milgrom, Therese Y. Andraos, Jillian R. Gunther, Linda Chi, Loretta Nastoupil, Nathan Fowler, Yasuhiro Oki, Michelle A. Fanale, Luis E. Fayad, Fredrick Hagemeister, Sattva S. Neelapu, L. Jeffrey Medeiros, Chitra Hosing, Yago Nieto, Sairah Ahmed, Amin M. Alousi, Bouthaina Dabaja & Chelsea C. Pinnix. (2018) Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy. Advances in Radiation Oncology 3:4, pages 639-646.
Crossref
Crossref
Michael Scordo, Sejal M. Morjaria, Eric R. Littmann, Ankush Bhatia, Helen H. Chung, Molly Maloy, Lisa M. DeAngelis, Sergio A. Giralt, Ying Taur & Craig S. Sauter. (2018) Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 24:9, pages 1914-1919.
Crossref
Crossref
Sylvain P. Chantepie, Sylvain Garciaz, Emmanuelle Tchernonog, Frederic Peyrade, Marie‐Virginie Larcher, Momar Diouf, Luc‐Mathieu Fornecker, Roch Houot, Thomas Gastinne, Carole Soussain, Sandra Malak, Richard Lemal, Caroline Delette, Ahmad Ibrahim, Anne‐Claire Gac, Emilie Reboursière, Jean‐Pierre Vilque, Mohamed‐Amine Bekadja, Rene‐Olivier Casasnovas, Remy Gressin, Stéphanie Guidez, Diane Coso, Charles Herbaux, Ibrahim Yakoub‐Agha, Krimo Bouabdallah, Eric Durot & Gandhi Damaj. (2018) Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers. American Journal of Hematology 93:6, pages 729-735.
Crossref
Crossref
Tomoko Yamashita, Yoshihiro Umezawa, Ken Watanabe, Tetsuya Fukuda, Norihiko Kawamata, Osamu Miura & Masahide Yamamoto. (2018) Busulfan-based conditioning regimen for autologous stem-cell transplantation in patients with central nervous system lymphoma中枢神経リンパ腫に対するブスルファンを含む前処置を用いた自家造血幹細胞移植の検討. Journal of Hematopoietic Cell Transplantation 7:4, pages 145-151.
Crossref
Crossref
Macarena I. De la Fuente & Antonio M. Omuro. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
455
468
.
David Qualls, Andrew Sullivan, Shuli Li, Andrew M. Brunner, Kerry Collier, Ephraim Hochberg, Philippe Armand, Tracy T. Batchelor, Yi-Bin Chen & Zachariah DeFilipp. (2017) High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement. Clinical Lymphoma Myeloma and Leukemia 17:12, pages 884-888.
Crossref
Crossref
Zachariah DeFilipp, Shuli Li, Areej El-Jawahri, Philippe Armand, Lakshmi Nayak, Nancy Wang, Tracy T. Batchelor & Yi-Bin Chen. (2017) High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission. Cancer 123:16, pages 3073-3079.
Crossref
Crossref
E Schorb, C P Fox, K Fritsch, L Isbell, A Neubauer, A Tzalavras, R Witherall, S Choquet, O Kuittinen, D De-Silva, K Cwynarski, C Houillier, K Hoang-Xuan, V Touitou, N Cassoux, J-P Marolleau, J Tamburini, R Houot, V Delwail, G Illerhaus, C Soussain & B Kasenda. (2017) High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study. Bone Marrow Transplantation 52:8, pages 1113-1119.
Crossref
Crossref
G Damaj, J Cornillon, K Bouabdallah, R Gressin, S Vigouroux, T Gastinne, F Ranchon, H Ghésquières, G Salles, I Yakoub-Agha & E Gyan. (2017) Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone Marrow Transplantation 52:7, pages 941-949.
Crossref
Crossref
Giovanni Citterio, Michele Reni, Gemma Gatta & Andrés José Maria Ferreri. (2017) Primary central nervous system lymphoma. Critical Reviews in Oncology/Hematology 113, pages 97-110.
Crossref
Crossref
Macarena I. de la Fuente & Lisa M. DeAngelis. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
871
882
.
Kento Umino, Shin-ichiro Fujiwara, Kazuya Sato, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Iekuni Oh, Ken Ohmine, Takahiro Suzuki, Kazuo Muroi & Yoshinobu Kanda. (2017) High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Acta Haematologica 137:2, pages 93-99.
Crossref
Crossref
Michael Scordo, Valkal Bhatt, Meier Hsu, Antonio M. Omuro, Matthew J. Matasar, Lisa M. DeAngelis, Parastoo B. Dahi, Craig H. Moskowitz, Sergio A. Giralt & Craig S. Sauter. (2017) A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning. Biology of Blood and Marrow Transplantation 23:1, pages 38-43.
Crossref
Crossref
Michel Zimmermann, Christoph Oehler, Ulrich Mey, Pirus Ghadjar & Daniel Rudolf Zwahlen. (2016) Radiotherapy for Non-Hodgkin’s lymphoma: still standard practice and not an outdated treatment option. Radiation Oncology 11:1.
Crossref
Crossref
Michael Crump. (2016) Management of Relapsed Diffuse Large B-cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1195-1213.
Crossref
Crossref
Hyunsoo Cho, Jong Hee Chang, Yu Ri Kim, Soo-Jeong Kim, Haerim Chung, Hyunsung Park, Jung Yeon Lee, Ji Eun Jang, Yundeok Kim, Se Hoon Kim, Woo Ick Yang, Chang-Ok Suh, June-Won Cheong, Yoo Hong Min & Jin Seok Kim. (2016) The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma. British Journal of Haematology 174:3, pages 444-453.
Crossref
Crossref
Andrés J. M. Ferreri & Gerald Illerhaus. (2016) The role of autologous stem cell transplantation in primary central nervous system lymphoma. Blood 127:13, pages 1642-1649.
Crossref
Crossref
Andreas F. Hottinger, Agusti Alentorn & Khê Hoang-Xuan. (2015) Recent developments and controversies in primary central nervous system lymphoma. Current Opinion in Oncology 27:6, pages 496-501.
Crossref
Crossref
Khê Hoang-Xuan, Eric Bessell, Jacoline Bromberg, Andreas F Hottinger, Matthias Preusser, Roberta Rudà, Uwe Schlegel, Tali Siegal, Carole Soussain, Ufuk Abacioglu, Nathalie Cassoux, Martina Deckert, Clemens M F Dirven, Andrés J M Ferreri, Francesc Graus, Roger Henriksson, Ulrich Herrlinger, Martin Taphoorn, Riccardo Soffietti & Michael Weller. (2015) Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. The Lancet Oncology 16:7, pages e322-e332.
Crossref
Crossref